(Q34339313)

English

Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

blood–brain barrier

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Chandrakantsing Vijaysing Pardeshi

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Veena Shailendra Belgamwar

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

16 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Expert Opinion on Drug Delivery

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

957-972

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Biomedical applications of nanotechnology--implications for drug targeting and gene therapy

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Brain distribution of ribavirin after intranasal administration

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Evaluation of brain-targeting for the nasal delivery of ergoloid mesylate by the microdialysis method in rats

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Potential of nanoparticulate drug delivery systems by intranasal administration.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Strategy for effective brain drug delivery.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Intranasal nanoemulsion based brain targeting drug delivery system of risperidone

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Micellar nanocarriers: potential nose-to-brain delivery of zolmitriptan as novel migraine therapy

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Nanoparticles for direct nose-to-brain delivery of drugs.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Nasal drug delivery--possibilities, problems and solutions

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Nasal clearance in health and disease

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Translocation of Inhaled Ultrafine Particles to the Brain

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Intranasal delivery to the central nervous system: mechanisms and experimental considerations

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, non-human primates and other mammalian species

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Evidence of antibody production in the rat cervical lymph nodes after antigen administration into the cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Drug transfer through mucus

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

The Transport of a Drug to the Cerebrospinal Fluid Directly from the Nasal Cavity: The Relation to the Lipophilicity of the Drug

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

In vivo toxicity and immunogenicity of wheat germ agglutinin conjugated poly(ethylene glycol)-poly(lactic acid) nanoparticles for intranasal delivery to the brain

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: application of factorial design approach

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Intranasal delivery of growth differentiation factor 5 to the central nervous system.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Central nervous system effects of intranasally administered insulin during euglycemia in men.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Lysosomal enzyme can bypass the blood-brain barrier and reach the CNS following intranasal administration

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Towards the therapeutic use of intranasal neuropeptide administration in metabolic and cognitive disorders

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Intranasal insulin as a therapeutic option in the treatment of cognitive impairments

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Intranasal insulin improves memory in humans

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Brain insulin signaling and Alzheimer's disease: current evidence and future directions

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Microparticles for intranasal immunization

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Levels of dopamine in blood and brain following nasal administration to rats

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Development of an ethyl laurate-based microemulsion for rapid-onset intranasal delivery of diazepam

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Intranasal delivery of cells to the brain.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Intranasal delivery of stem cells to the brain

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Intranasal delivery of biologics to the central nervous system

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Stem cell transplantation for neurometabolic and neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Mesenchymal stem cells as therapeutic agents and potential targeted gene delivery vehicle for brain diseases

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease.

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

CNS drug delivery systems: novel approaches

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2013.790887

21 January 2018

Identifiers

10.1517/17425247.2013.790887

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34339313&oldid=1616080151"